Bank of New York Mellon Corp lowered its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON – Get Rating) by 2.0% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 692,511 shares of the biotechnology company’s stock after selling 14,231 shares during the period. Bank of New York Mellon Corp owned about 0.97% of Axon Enterprise worth $80,158,000 at the end of the most recent reporting period.
Several other hedge funds have also recently added to or reduced their stakes in the company. Capital International Investors lifted its stake in Axon Enterprise by 605.2% during the first quarter. Capital International Investors now owns 2,660,634 shares of the biotechnology company’s stock worth $366,449,000 after purchasing an additional 2,283,343 shares during the last quarter. State Street Corp lifted its stake in Axon Enterprise by 1.0% during the second quarter. State Street Corp now owns 2,242,477 shares of the biotechnology company’s stock worth $208,932,000 after purchasing an additional 21,785 shares during the last quarter. Stephens Investment Management Group LLC lifted its stake in Axon Enterprise by 3.3% during the third quarter. Stephens Investment Management Group LLC now owns 597,921 shares of the biotechnology company’s stock worth $69,209,000 after purchasing an additional 19,019 shares during the last quarter. Northern Trust Corp lifted its stake in Axon Enterprise by 2.6% during the first quarter. Northern Trust Corp now owns 534,884 shares of the biotechnology company’s stock worth $73,669,000 after purchasing an additional 13,404 shares during the last quarter. Finally, Invesco Ltd. lifted its stake in Axon Enterprise by 11.0% during the first quarter. Invesco Ltd. now owns 456,345 shares of the biotechnology company’s stock worth $62,852,000 after purchasing an additional 45,308 shares during the last quarter. Institutional investors own 75.62% of the company’s stock.
Axon Enterprise Stock Up 2.8 %
Shares of NASDAQ:AXON opened at $219.68 on Wednesday. Axon Enterprise, Inc. has a 1 year low of $82.49 and a 1 year high of $226.00. The company has a market cap of $16.01 billion, a PE ratio of 107.69 and a beta of 0.92. The company has a debt-to-equity ratio of 0.53, a current ratio of 3.00 and a quick ratio of 2.66. The stock’s 50-day moving average is $199.26 and its 200 day moving average is $169.44.
Insider Activity at Axon Enterprise
In other Axon Enterprise news, President Luke Larson sold 3,711 shares of the company’s stock in a transaction that occurred on Tuesday, December 27th. The stock was sold at an average price of $168.73, for a total transaction of $626,157.03. Following the transaction, the president now owns 272,917 shares in the company, valued at approximately $46,049,285.41. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other Axon Enterprise news, Director Mark W. Kroll sold 3,549 shares of the company’s stock in a transaction that occurred on Tuesday, March 7th. The stock was sold at an average price of $220.73, for a total transaction of $783,370.77. Following the transaction, the director now owns 10,142 shares in the company, valued at approximately $2,238,643.66. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, President Luke Larson sold 3,711 shares of the company’s stock in a transaction that occurred on Tuesday, December 27th. The stock was sold at an average price of $168.73, for a total value of $626,157.03. Following the transaction, the president now owns 272,917 shares in the company, valued at approximately $46,049,285.41. The disclosure for this sale can be found here. Insiders have sold a total of 344,672 shares of company stock worth $65,155,942 in the last 90 days. Company insiders own 6.90% of the company’s stock.
Analysts Set New Price Targets
AXON has been the subject of several research analyst reports. Needham & Company LLC reaffirmed a “buy” rating and set a $240.00 price target on shares of Axon Enterprise in a research note on Wednesday, March 1st. StockNews.com assumed coverage on Axon Enterprise in a research note on Thursday, March 16th. They issued a “hold” rating for the company. Robert W. Baird boosted their target price on Axon Enterprise from $200.00 to $237.00 and gave the company an “outperform” rating in a research note on Wednesday, March 1st. Credit Suisse Group boosted their target price on Axon Enterprise from $200.00 to $237.00 and gave the company an “outperform” rating in a research note on Wednesday, March 1st. Finally, Morgan Stanley boosted their target price on Axon Enterprise from $130.00 to $155.00 and gave the company an “equal weight” rating in a research note on Tuesday, December 13th. Three analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $221.64.
Axon Enterprise Profile
Axon Enterprise, Inc engages in the development, manufacture, and sale of conducted electrical weapons for personal defense. It operates through the TASER segment and Software and Sensors segment. The TASER segment sells conducted electrical weapons, accessories, and other related products and services.
Featured Articles
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXON – Get Rating).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Axon Enterprise, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Axon Enterprise wasn’t on the list.
While Axon Enterprise currently has a “Moderate Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
